MOIL Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 8:34 pm

Quick Insight

MOIL Ltd, a key player in the mining and minerals industry, currently trades at a price of 325 with a market capitalization of 6,618 crore. The stock shows a P/E ratio of 23.6, ROE of 15.0%, and ROCE of 19.1%, indicating solid profitability and efficient capital utilization. With an OPM of 23%, the company has maintained a healthy operational performance. The balance sheet reveals strong reserves of 2,434 crore and zero borrowings, reflecting a robust financial position. Furthermore, the shareholder distribution includes significant promoter holding at 64.68%, while institutional investors hold a combined stake of 13.48%. Despite a P/BV of 0.87x, suggesting a potential undervaluation, the company's performance metrics indicate a strong foundation for future growth and value creation in the mining sector.

Competitors of MOIL Ltd

All Competitor Stocks of MOIL Ltd

Quarterly Result

Last Updated: August 1, 2025, 4:55 pm

Below is a detailed analysis of the quarterly data for MOIL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 348.00 Cr.. The value appears to be declining and may need further review. It has decreased from 433.00 Cr. (Mar 2025) to 348.00 Cr., marking a decrease of 85.00 Cr..
• For Expenses, as of Jun 2025, the value is 269.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 294.00 Cr. (Mar 2025) to 269.00 Cr., marking a decrease of 25.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 140.00 Cr. (Mar 2025) to 79.00 Cr., marking a decrease of 61.00 Cr..
• For OPM %, as of Jun 2025, the value is 23.00%. The value appears to be declining and may need further review. It has decreased from 32.00% (Mar 2025) to 23.00%, marking a decrease of 9.00%.
• For Other Income, as of Jun 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 25.00 Cr. (Mar 2025) to 22.00 Cr., marking a decrease of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 37.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 39.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 64.00 Cr.. The value appears to be declining and may need further review. It has decreased from 125.00 Cr. (Mar 2025) to 64.00 Cr., marking a decrease of 61.00 Cr..
• For Tax %, as of Jun 2025, the value is 19.00%. The value appears to be increasing, which may not be favorable. It has increased from 8.00% (Mar 2025) to 19.00%, marking an increase of 11.00%.
• For Net Profit, as of Jun 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 116.00 Cr. (Mar 2025) to 52.00 Cr., marking a decrease of 64.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.53. The value appears to be declining and may need further review. It has decreased from 5.68 (Mar 2025) to 2.53, marking a decrease of 3.15.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 3, 2025, 1:51 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:05 pm

Below is a detailed analysis of the balance sheet data for MOIL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 203.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 203.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,434.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,250.00 Cr. (Mar 2024) to 2,434.00 Cr., marking an increase of 184.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 573.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 436.00 Cr. (Mar 2024) to 573.00 Cr., marking an increase of 137.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,211.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,889.00 Cr. (Mar 2024) to 3,211.00 Cr., marking an increase of 322.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 962.00 Cr.. The value appears strong and on an upward trend. It has increased from 926.00 Cr. (Mar 2024) to 962.00 Cr., marking an increase of 36.00 Cr..
• For CWIP, as of Mar 2025, the value is 465.00 Cr.. The value appears strong and on an upward trend. It has increased from 357.00 Cr. (Mar 2024) to 465.00 Cr., marking an increase of 108.00 Cr..
• For Investments, as of Mar 2025, the value is 78.00 Cr.. The value appears to be declining and may need further review. It has decreased from 128.00 Cr. (Mar 2024) to 78.00 Cr., marking a decrease of 50.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,707.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,478.00 Cr. (Mar 2024) to 1,707.00 Cr., marking an increase of 229.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,211.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,889.00 Cr. (Mar 2024) to 3,211.00 Cr., marking an increase of 322.00 Cr..

Notably, the Reserves (2,434.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for MOIL Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 20, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 20, the value is 9.80. This value is within the healthy range. It has decreased from 18.57 (Mar 19) to 9.80, marking a decrease of 8.77.
• For Diluted EPS (Rs.), as of Mar 20, the value is 9.80. This value is within the healthy range. It has decreased from 18.57 (Mar 19) to 9.80, marking a decrease of 8.77.
• For Cash EPS (Rs.), as of Mar 20, the value is 14.51. This value is within the healthy range. It has decreased from 21.20 (Mar 19) to 14.51, marking a decrease of 6.69.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 116.44. It has decreased from 119.67 (Mar 19) to 116.44, marking a decrease of 3.23.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 116.44. It has decreased from 119.67 (Mar 19) to 116.44, marking a decrease of 3.23.
• For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 43.74. It has decreased from 55.92 (Mar 19) to 43.74, marking a decrease of 12.18.
• For PBDIT / Share (Rs.), as of Mar 20, the value is 18.40. This value is within the healthy range. It has decreased from 30.74 (Mar 19) to 18.40, marking a decrease of 12.34.
• For PBIT / Share (Rs.), as of Mar 20, the value is 14.34. This value is within the healthy range. It has decreased from 28.15 (Mar 19) to 14.34, marking a decrease of 13.81.
• For PBT / Share (Rs.), as of Mar 20, the value is 14.34. This value is within the healthy range. It has decreased from 28.15 (Mar 19) to 14.34, marking a decrease of 13.81.
• For Net Profit / Share (Rs.), as of Mar 20, the value is 10.46. This value is within the healthy range. It has decreased from 18.60 (Mar 19) to 10.46, marking a decrease of 8.14.
• For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 10.46. This value is within the healthy range. It has decreased from 18.57 (Mar 19) to 10.46, marking a decrease of 8.11.
• For PBDIT Margin (%), as of Mar 20, the value is 42.05. This value is within the healthy range. It has decreased from 54.97 (Mar 19) to 42.05, marking a decrease of 12.92.
• For PBIT Margin (%), as of Mar 20, the value is 32.79. This value exceeds the healthy maximum of 20. It has decreased from 50.33 (Mar 19) to 32.79, marking a decrease of 17.54.
• For PBT Margin (%), as of Mar 20, the value is 32.79. This value is within the healthy range. It has decreased from 50.33 (Mar 19) to 32.79, marking a decrease of 17.54.
• For Net Profit Margin (%), as of Mar 20, the value is 23.90. This value exceeds the healthy maximum of 10. It has decreased from 33.26 (Mar 19) to 23.90, marking a decrease of 9.36.
• For NP After MI And SOA Margin (%), as of Mar 20, the value is 23.91. This value exceeds the healthy maximum of 20. It has decreased from 33.21 (Mar 19) to 23.91, marking a decrease of 9.30.
• For Return on Networth / Equity (%), as of Mar 20, the value is 8.98. This value is below the healthy minimum of 15. It has decreased from 15.52 (Mar 19) to 8.98, marking a decrease of 6.54.
• For Return on Capital Employeed (%), as of Mar 20, the value is 12.23. This value is within the healthy range. It has decreased from 23.39 (Mar 19) to 12.23, marking a decrease of 11.16.
• For Return On Assets (%), as of Mar 20, the value is 7.52. This value is within the healthy range. It has decreased from 13.27 (Mar 19) to 7.52, marking a decrease of 5.75.
• For Asset Turnover Ratio (%), as of Mar 20, the value is 0.30. It has decreased from 0.42 (Mar 19) to 0.30, marking a decrease of 0.12.
• For Current Ratio (X), as of Mar 20, the value is 4.57. This value exceeds the healthy maximum of 3. It has decreased from 5.53 (Mar 19) to 4.57, marking a decrease of 0.96.
• For Quick Ratio (X), as of Mar 20, the value is 4.22. This value exceeds the healthy maximum of 2. It has decreased from 5.33 (Mar 19) to 4.22, marking a decrease of 1.11.
• For Inventory Turnover Ratio (X), as of Mar 20, the value is 0.11. This value is below the healthy minimum of 4. It has decreased from 0.38 (Mar 19) to 0.11, marking a decrease of 0.27.
• For Dividend Payout Ratio (NP) (%), as of Mar 20, the value is -72.11. This value is below the healthy minimum of 20. It has decreased from 29.61 (Mar 19) to -72.11, marking a decrease of 101.72.
• For Dividend Payout Ratio (CP) (%), as of Mar 20, the value is -51.97. This value is below the healthy minimum of 20. It has decreased from 25.98 (Mar 19) to -51.97, marking a decrease of 77.95.
• For Earning Retention Ratio (%), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 70.39 (Mar 19) to 0.00, marking a decrease of 70.39.
• For Cash Earning Retention Ratio (%), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 74.02 (Mar 19) to 0.00, marking a decrease of 74.02.
• For Enterprise Value (Cr.), as of Mar 20, the value is 584.28. It has decreased from 1,834.06 (Mar 19) to 584.28, marking a decrease of 1,249.78.
• For EV / Net Operating Revenue (X), as of Mar 20, the value is 0.56. This value is below the healthy minimum of 1. It has decreased from 1.27 (Mar 19) to 0.56, marking a decrease of 0.71.
• For EV / EBITDA (X), as of Mar 20, the value is 1.34. This value is below the healthy minimum of 5. It has decreased from 2.32 (Mar 19) to 1.34, marking a decrease of 0.98.
• For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 2.32. This value is within the healthy range. It has decreased from 2.84 (Mar 19) to 2.32, marking a decrease of 0.52.
• For Retention Ratios (%), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 70.38 (Mar 19) to 0.00, marking a decrease of 70.38.
• For Price / BV (X), as of Mar 20, the value is 0.87. This value is below the healthy minimum of 1. It has decreased from 1.33 (Mar 19) to 0.87, marking a decrease of 0.46.
• For Price / Net Operating Revenue (X), as of Mar 20, the value is 2.32. This value is within the healthy range. It has decreased from 2.84 (Mar 19) to 2.32, marking a decrease of 0.52.
• For EarningsYield, as of Mar 20, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 19) to 0.10, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness